Abound Wealth Management
- SEC CIK
- 0001950323
- Latest filing
- Jul 10, 2026
ADIL holding history
Adial Pharmaceuticals, Inc. in every 13F filed by Abound Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADIL overviewAll 13F holders of ADILFull Q2 2026 holdings
- Shares (Q2 2026)
- 1
- Value
- $3
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $3 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1 | $2 | <0.1% | −0−7.4% | ReducedConverted for a 1-for-25 split | Holders |
| Q4 2025 | 27 | $6 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 27 | $10 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 27 | $9 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 27 | $18 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 27 | $28 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 27 | $27 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 27 | $32 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 27 | $36 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 27 | $51 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 27 | $76 | <0.1% | +27 | New | Holders |